| abstract |
The invention relates to a use of a gas mixture containing gaseous xenon and nitrous oxide gas, and advantageously oxygen, for manufacturing all or part of an inhalable medicament intended for preventing or treating neuro- intoxication in humans. The xenon / nitrous oxide mixture of the invention acts on one or more brain receptors so as to decrease the release and / or the effects of dopamine, glutamate, serotonin, taurine, GABA, noradrenaline and / or any other neurotransmitter. The proportion by volume of xenon of the mixture is between 5 and 45%, and the proportion by volume of nitrous oxide is between 10 and 50%, preferably the remainder is oxygen. |